European Archives - Page 361 of 1424 - European Medical Journal

Physical Activity Boosts Mental Health in Women with Chronic Pelvic Pain

A recent study tracking over 4,000 days of health data has found that physical activity plays a crucial role in improving mental well-being in women with chronic pelvic pain disorders.

Elevated Salivary Microvesicles Linked to Oral Ulcers and Cancer

Elevated salivary microvesicles are linked to non-healing oral ulcers and oral cancer, potentially aiding in early diagnosis.

HIV Cure Trial in African Women Shows Early Promise

A groundbreaking Phase IIa HIV cure study in South Africa has demonstrated the safety and potential efficacy of a novel therapeutic regimen in women with HIV.

How Alcohol Harms the Digestive System

Despite the significant health burden, there are gaps in managing alcohol-related digestive diseases.

Why Sexual Health Deserves More Attention in Medicine

In this episode of the EMJ Podcast, Jonathan Sackier speaks with Rachel Rubin, a urologist and sexual medicine specialist, about the need for patient-centred care, the importance of multidisciplinary approaches, and breaking the stigma around sexual health.

Psoriasis Treatment Study Confirms Biosimilar Effectiveness

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira.

Evaluation of Antimicrobial Resistance Patterns in Afghanistan

Existing studies reveal alarming levels of AMR in Afghanistan, driven by factors such as self-medication, overuse of antibiotics, and inadequate awareness…

Pfizer completes exit from Haleon

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.

Neurodegeneration and Cardiovascular Health: New Insights on Racial Differences

Better heart health cuts neurodegeneration biomarkers by 19% in the elderly, but racial disparities in CVH highlight need for targeted interventions.

AI-Driven Platform Predicts Outcomes in High-Risk Bladder Cancer

Notably, AI-driven models outperformed traditional clinical risk calculators like the EORTC and EAU models.